ON DEMAND

Addressing Global Inequalities in Comprehensive Cancer Care

Liquid biopsy is emerging as a revolutionary technology, offering swift and precise diagnostics. It has the potential to significantly impact precision oncology by providing a non-invasive approach for cancer detection, monitoring, and treatment selection. However, liquid biopsy still faces challenges, including workflow standardization and broad adoption across the globe.

Join us for this webinar to learn more about the collaborative efforts of SOPHiA GENETICS, Memorial Sloan Kettering Cancer Center, and AstraZeneca in enhancing global access to and adoption of MSK-ACCESS® powered with SOPHiA DDM™, aimed at addressing disparities in cancer care.

Key topics:

Transforming Cancer Care with MSK-ACCESS® powered with SOPHiA DDM™
Closing the Gap: Reducing Inequalities in Global Cancer Care
Strategic Alliances for Healthcare Innovation: Lessons from SOPHiA GENETICS, MSK, and AstraZeneca

Date it was presented - 5th September 2024

Watch On Demand

First Name

Last Name

Institution

Job Title

Country

State

Comments

Privacy Policy I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. View our Privacy Policy for more information.

Pardot Opt-in I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able to unsubscribe by using the link integrated with the communication at any time.

Comments